Bladder cancer and the National Cancer Data Base: New insight or misinformation?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cancer

• Publication date

  2018-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.31210PMID 29338078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.

  2018cited by this paper
• Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer.

  2017cited by this paper
• Using the National Cancer Database for Outcomes Research: A Review

  2017cited by this paper
• Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder‐preservation therapy for muscle‐invasive bladder cancer

  2017cited by this paper
• Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy

  2017cited by this paper
• Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.

  2017cited by this paper
• Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials.

  2016cited by this paper
• Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)

  2016cited by this paper
• Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.

  2015cited by this paper
• Considerations for observational research using large data sets in radiation oncology.

  2014cited by this paper
• Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

  2014cited by this paper
• Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study.

  2014cited by this paper
• Results of the SPARE Feasibility Study – Selective Bladder Preservation Against Radical Excision in Muscle Invasive T2/T3 Transitional Cell Carcinoma of the Bladder (CRUK/07/011)

  2012cited by this paper
• International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

  2011cited by this paper
• Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)

  2011cited by this paper
• Results of a phase III randomized trial of synchronous chemoradiotherapy (CRT) compared to radiotherapy (RT) alone in muscle-invasive bladder cancer (MIBC) (BC2001 CRUK/01/004).

  2010cited by this paper
• Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.

  2010cited by this paper
• Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.

  2008cited by this paper

• A Comprehensive Guide to Supportive Care and Unmet Needs in Breast Cancer

  2025cites this paper
• Small-cell neuroendocrine tumor of the bladder: Unexpected long-term survival with carboplatin-etoposide therapy in a patient with metastatic stage disease

  2023cites this paper
• Real-world data: towards achieving the achievable in cancer care

  2019cites this paper
• Effectiveness in the Absence of Efficacy: Cautionary Tales From Real-World Evidence.

  2019cites this paper
• Identifying and Codifying Complications after Radical Cystectomy: Comparison of Administrative Diagnostic and Procedure Codes and Clinical Chart Review.

  2019cites this paper
• National cancer database analysis of outcomes in pediatric glioblastoma

  2018cites this paper